Mimecast Named One of the Highest-Rated Public Cloud Computing Companies to Work For
Nov 01, 2016 12:30 pm UTC| Business
Watertown,MA, Nov. 01, 2016 -- Mimecast Limited (NASDAQ: MIME), a leading email and data security company, was recognized as one of the 25 Highest Rated Public Cloud Computing Companies To Work For in a new list...
Sientra Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Nov 01, 2016 12:30 pm UTC| Business
SANTA BARBARA, Calif., Nov. 01, 2016 -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra”), a medical aesthetics company, today announced that it has granted a nonstatutory stock option under its Inducement Plan for 300,000 shares...
Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2016 Financial Results
Nov 01, 2016 12:30 pm UTC| Business
SOLANA BEACH, Calif., Nov. 01, 2016 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it will issue its financial...
Rubicon Global Co-Founder Marc Spiegel Named a 2016 Atlanta Business Chronicle 40 Under 40 Honoree
Nov 01, 2016 12:30 pm UTC| Business
ATLANTA, Nov. 01, 2016 -- Rubicon Global, the worldwide leader in sustainable, cloud-based waste and recycling solutions, announced today that co-founder Marc Spiegel has been named to the Atlanta Business Chronicle’s...
Nov 01, 2016 12:30 pm UTC| Business
NEW YORK and LONDON, Nov. 01, 2016 -- Although financial services firms are moving to adopt cloud computing for less demanding workloads, firm-managed physical hardware will be required for the foreseeable future to...
EV Energy Partners Announces Reaffirmation of $450 million Borrowing Base
Nov 01, 2016 12:15 pm UTC| Business
HOUSTON, Nov. 01, 2016 -- EV Energy Partners, L.P. (Nasdaq:EVEP) today announced that it has completed its fall 2016 semi-annual borrowing base redetermination under its revolving credit facility (“Facility”). The...
Nov 01, 2016 12:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2016 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...